CXCR4 and esophageal squamous cell carcinoma: Wang et al. showed that there was a significant difference in 5-year survival rates between ESCC patients with positive and negative SDF-1α, while the CXCR4-positive group had better 5-year survival rates compared to those with CXCR4- negative [10].